Literature DB >> 1964222

Pentobarbital tolerance and withdrawal: correlation with effects on the GABAA receptor.

P A Saunders1, Y Ito, M L Baker, A S Hume, I K Ho.   

Abstract

A model for the development of pentobarbital tolerance and dependence was characterized and correlated with changes in radioligand binding to the GABAA-benzodiazepine receptor chloride channel complex. While one day of pentobarbital exposure decreased the duration of loss of righting reflex, tolerance to the hypothermic effects of thiopental and barbital took 7 days to develop, indicating that pharmacokinetic and pharmacodynamic tolerance are separable. Increased sensitivity to pentylenetetrazol-induced seizures was first observed after 3 days of pentobarbital exposure, suggesting brain areas involved in seizure control develop tolerance to, and dependence on pentobarbital faster than those involved in temperature regulation. Acute exposure to pentobarbital in vivo did not affect cortical binding of [3H]muscimol in vitro, while tolerance caused a decrease in binding due to an increase in the low-affinity site KD. Pentobarbital tolerance also caused a decrease in the cortical binding of the benzodiazepine, [3H]flunitrazepam. These observations suggest that the acute effects of barbiturates on the GABAA receptor complex are reversible, while tolerance causes receptor modifications which may be related to the development of physical dependence.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1964222     DOI: 10.1016/0091-3057(90)90346-j

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  5 in total

1.  Effects of pentobarbital tolerance to and dependence on GABAB receptor-binding.

Authors:  T Kimura; P A Saunders; I Yamamoto; I K Ho
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

Review 2.  Tolerance to allopregnanolone with focus on the GABA-A receptor.

Authors:  Sahruh Turkmen; Torbjorn Backstrom; Goran Wahlstrom; Lotta Andreen; Inga-Maj Johansson
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

3.  Acute and subchronic benzodiazepine-barbiturate-interactions on behaviour and physiological responses of the mouse.

Authors:  J Wolffgramm; C Mikolaiczyk; H Coper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

4.  Binding characteristics of [3H]flunitrazepam in pentobarbital-withdrawal rats.

Authors:  T Miyaoka; T Kimura; P A Saunders; Y T Tseng; I K Ho
Journal:  Neurochem Res       Date:  1994-01       Impact factor: 3.996

5.  First-in-man allopregnanolone use in super-refractory status epilepticus.

Authors:  Henrikas Vaitkevicius; Aatif M Husain; Eric S Rosenthal; Jonathan Rosand; Wendell Bobb; Kiran Reddy; Michael A Rogawski; Andrew J Cole
Journal:  Ann Clin Transl Neurol       Date:  2017-04-26       Impact factor: 4.511

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.